Option 02-1

Posts in clinical outcome

Baltimore, Maryland, 2020.08.27 - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in ...

Read More →